These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18088553)

  • 1. Immunophenotypic peculiarities of mobilized stem (CD34+) cells in blood from patients with severe spinal cord injury.
    Tupitsyn NN; Yaryghin VN; Bryukhovetskiy AS; Grivtsova LY; Mentkevich GL; Dolgopolov IS; Zaitsev AY; Davydov MI
    J Biol Regul Homeost Agents; 2006; 20(1-2):36-40. PubMed ID: 18088553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
    Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC
    Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
    Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
    Transplantation; 2008 Sep; 86(5):686-96. PubMed ID: 18791450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
    Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
    Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and stress related phenotypical changes in bone marrow CD34+ cells.
    Taraldsrud E; Grøgaard HK; Solheim S; Lunde K; Fløisand Y; Arnesen H; Seljeflot I; Egeland T
    Scand J Clin Lab Invest; 2009; 69(1):79-84. PubMed ID: 18836945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction.
    McQualter JL; Brouard N; Williams B; Baird BN; Sims-Lucas S; Yuen K; Nilsson SK; Simmons PJ; Bertoncello I
    Stem Cells; 2009 Mar; 27(3):623-33. PubMed ID: 19074419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
    Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
    Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
    Fatrai S; Schepers H; Tadema H; Vellenga E; Daenen SM; Schuringa JJ
    Exp Hematol; 2008 Oct; 36(10):1254-65. PubMed ID: 18640764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic capacity of preterm cord blood hematopoietic stem/progenitor cells.
    Nakajima M; Ueda T; Migita M; Oue Y; Shima Y; Shimada T; Fukunaga Y
    Biochem Biophys Res Commun; 2009 Nov; 389(2):290-4. PubMed ID: 19720051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental/umbilical cord blood-derived mesenchymal stem cell-like stromal cells support hematopoietic recovery of X-irradiated human CD34+ cells.
    Hayashi N; Takahashi K; Abe Y; Kashiwakura I
    Life Sci; 2009 Apr; 84(17-18):598-605. PubMed ID: 19302805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
    Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
    Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.